Department of Health Sciences, Lund University, Box 157 SE 221 00, Lund, Sweden.
PM R. 2012 Oct;4(10):734-8. doi: 10.1016/j.pmrj.2012.05.004. Epub 2012 Jul 4.
To assess self-reported walking ability in individuals with chronic stroke and to determine the relationship with gait performance tests.
Descriptive analysis of a convenience sample.
A university hospital rehabilitation medicine clinic.
Fifty ambulatory community-dwelling poststroke individuals (mean age, 64 years [range, 44-74 years] and mean time since stroke onset 42 months [range, 6-101 months]).
The Walking Impact Scale (the Walk-12) to assess self-reported walking ability, and the Timed "Up & Go" test, 10-m Comfortable Gait Speed and Fast Gait Speed tests, and 6-Minute Walk Test to assess gait performance.
A majority of the participants (94%) reported limitations in their walking ability. The most common limitations were related to standing or walking, walking speed and distance, effort, and gait quality aspects. The ability to run was reported as most affected, whereas the need for support indoors or outdoors was least affected. Significant correlations (P < .01) were found between the Walk-12 and the 4 gait performance tests (ρ = -0.60 to 0.60).
Persons with chronic stroke perceive limitations in their walking ability. The relationship between the Walk-12 and the 4 gait performance tests indicates that self-reports and quantitative assessments are associated. Because the Walk-12 reflects broader dimensions than the gait performance tests, it can be a complementary tool when walking ability in persons with chronic stroke is evaluated.
评估慢性脑卒中患者的自我报告步行能力，并确定其与步态表现测试的关系。
便利样本的描述性分析。
一所大学医院康复医学诊所。
50 名有行走能力的社区居住的慢性脑卒中患者（平均年龄 64 岁[范围：44-74 岁]，平均脑卒中发病后时间 42 个月[范围：6-101 个月]）。
评估自我报告步行能力的步行影响量表（Walk-12），以及计时“站起-行走”测试、10 米舒适行走速度和快速行走速度测试、6 分钟步行测试，以评估步态表现。
大多数患者（94%）报告存在步行能力受限。最常见的受限与站立或行走、行走速度和距离、费力和步态质量方面相关。能跑动的能力被认为受影响最严重，而对室内或室外的支持需求受影响最小。Walk-12 与 4 项步态表现测试之间存在显著相关性（P <.01）（ρ = -0.60 至 0.60）。
慢性脑卒中患者感知到步行能力受限。Walk-12 与 4 项步态表现测试之间的关系表明，自我报告和定量评估是相关的。由于 Walk-12 反映的维度比步态表现测试更广泛，因此在评估慢性脑卒中患者的步行能力时，它可以作为一种补充工具。
